External Contributer Articles of Labiotech.eu

About

Many authors are contributing to Labiotech.eu. If you want to join them, feel free to reach out to us with your article ideas.

Articles by External Contributor

Opinion 24 Oct 2022

Hiding in plain sight: how to solve bioscience’s software problem

Guy Levy-Yurista, CEO of the experiment platform developer Synthace, gives his take on what’s missing in increasingly software-dependent life sciences labs: a holistic mindset for improving experimental methods. There’s a major problem holding back progress in biotech, and more widely in the life sciences. It’s not an obvious one, but based on the conversations I […]

October 24, 2022 - 5 minutesmins - By External Contributor

News and Trends 20 Oct 2022

The role of long-read sequencing in validating CRISPR outcomes

Neil Ward, general manager of PacBio EMEA With applications of CRISPR across the spectrum of microbial, plant and gene therapy increasingly being realised, enthusiasm from the research community for this technology is not expected to wane. It has the potential to, among other applications, create knock-out animal models for use in research, revolutionise agriculture and […]

October 20, 2022 - 3 minutesmins - By External Contributor

CRISPR Therapeutics, CRISPR-Cas9, genome editing, biotech

News and Trends 17 Oct 2022

CRISPR/Cas9: Challenges and outlook from an investor’s perspective

A Q&A with Fady Riad, CEO of consulting company Centurion Life Sciences. How did CRISPR/Cas9 revolutionize gene editing and the broader life sciences industry? CRISPR/Cas9 is undoubtedly one of the greatest scientific advancements of the last 100 years. In 2012, Jennifer Doudna and Emanuelle Charpentier published a peer-reviewed paper discussing the use of CRISPR/Cas9 in […]

October 17, 2022 - 6 minutesmins - By External Contributor

Using the power of proteomics to predict immunotherapy responses in melanoma and beyond

Next-generation proteomics has a vital role to play in the search for new biomarkers of immunotherapy response. Recent studies in melanoma presented at the European Society for Medical Oncology (ESMO) Congress highlight how these insights have the potential to transform cancer care. The recent success of immunotherapies that manipulate the patient’s immune system to recognize […]

September 27, 2022 - 6 minutesmins - By External Contributor

More News! 13 Sep 2022

Research charity calls on scientists, engineers, and technology experts to transform dialysis treatment

Following its successful MedTech competition earlier this year, the UK’s largest kidney research charity, Kidney Research UK, has launched a new competition aimed at innovations in dialysis that will have a significant impact on patients’ lives. In collaboration with IN-PART’s Discover platform, this year’s competition will encourage scientists, academics, engineers and technology experts to propose […]

September 13, 2022 - 3 minutesmins - By External Contributor

Opinion 6 Sep 2022

Meeting tech transfer challenges when manufacturing new biopharmaceuticals

With increasingly complex therapeutics arriving almost monthly, efficient technology transfer between biopharma and manufacturers is more important than ever. Ken Forman, senior director of product strategy at IDBS, explains how good digital strategies can avoid common pitfalls in the tech transfer process. Biopharmaceutical lifecycle management (BPLM) is the key to delivering novel therapies and lifesaving […]

September 6, 2022 - 7 minutesmins - By External Contributor

francine kaufman senseomics diabetes management

Opinion 1 Sep 2022

The evolution of diabetes management

Diabetes management has progressed leaps and bounds in the last 100 years. Francine Kaufman, Chief Medical Officer of Senseonics, outlines how far the field has progressed and what is on the horizon for diabetes patients. This year marks 100 years since insulin was first available to treat diabetes – an incredible milestone. One of the […]

September 1, 2022 - 6 minutesmins - By External Contributor

Opinion 8 Aug 2022

Building a healthtech industry in Europe to serve patients

By Maryvonne Hiance, president of HealthTech For Care; and Christian Pierret, Former Minister Delegate for Industry The HealthTech For Care endowment fund, launched by France Biotech is designed to support and promote access to care for all and, more specifically, to new medical technologies and drugs. Europe is just emerging from a health crisis that […]

August 8, 2022 - 5 minutesmins - By External Contributor

sano genetics trial recruitment precision medicine

Opinion 25 Jul 2022

How to improve patient recruitment in your precision medicine research

Precision medicine research relies on genetic testing at scale, but has long suffered recruitment and retention headaches. The answer, says Patrick Short, CEO of Sano Genetics, is to start early and engage participants deeply. I witnessed first-hand the power of national scale genomics research through my PhD work analyzing genome sequence data from more than […]

July 25, 2022 - 7 minutesmins - By External Contributor

Inside Labiotech 20 Jul 2022

Connecting the R&D ecosystem: 150 days into the integration of Inova, IN-PART and Labiotech

Hear from the leadership teams at Inova, IN-PART and Labiotech about how the integration of the three companies is taking shape and the impacts it will have on the R&D ecosystem. The acquisition of IN-PART and Labiotech by Inova in January signaled the intent and ambition to combine the efforts of three companies focused on […]

July 20, 2022 - 5 minutesmins - By External Contributor

More News! 19 Jul 2022

Bayer Consumer Health launches microbiome research call to find new academic partners

Campaign launch date: Monday, July 18, 2022. Bayer Consumer Health has launched a call through IN-PART’s Discover platform to find and partner with academic experts and research groups working on microbiome-targeting solutions for upper respiratory illnesses, nutrition and digestive health as well as topical delivery through the skin. The campaign aims to accelerate Bayer’s “Partnering […]

July 19, 2022 - 3 minutesmins - By External Contributor

multiOmics Health metabolic disorders precision medicine

Opinion 11 Jul 2022

Precision medicine: the next big leap for metabolic disorders

Chronic metabolic disorders like type 2 diabetes and cardiovascular disease are a huge burden on healthcare systems, and their treatment is often fragmented and reliant on trial-and-error approaches. Rebecca Cripps and Robert Thong at MultiOmic Health explain how precision medicine is set to change the way we think about these disorders. Metabolic disorders constitute the […]

July 11, 2022 - 6 minutesmins - By External Contributor

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

External Contributor

About

Articles by External Contributor

Hiding in plain sight: how to solve bioscience’s software problem

The role of long-read sequencing in validating CRISPR outcomes

CRISPR/Cas9: Challenges and outlook from an investor’s perspective

Using the power of proteomics to predict immunotherapy responses in melanoma and beyond

Research charity calls on scientists, engineers, and technology experts to transform dialysis treatment

Meeting tech transfer challenges when manufacturing new biopharmaceuticals

The evolution of diabetes management

Building a healthtech industry in Europe to serve patients

How to improve patient recruitment in your precision medicine research

Connecting the R&D ecosystem: 150 days into the integration of Inova, IN-PART and Labiotech

Bayer Consumer Health launches microbiome research call to find new academic partners

Precision medicine: the next big leap for metabolic disorders

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

About

Articles by External Contributor

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!